How Tracking DOLs and Treatment Leaders will Revolutionize Pharma

This webinar dives into how to find and source HCPs on the forefront of their therapeutic areas. These HCPs may also be rising key opinion leaders, also called digital opinion leaders, have a digital footprint and share scientific exchange through digital channels like Twitter or LinkedIn or treat a high volume of patients.
Nayanica Banerjee, H1's Senior Manager of Strategic Client Solutions, presents:
Learn about the recent history and evolution of pharma thought leaders beyond traditional KOLs - digital opinion leaders (DOLs) and treatments leaders- how they are defined.
Analyze recent market trends related to how MSLs and Medical Affairs teams view non-traditional KOLs and DOLs.
Review a few best practices for leveraging data to find and follow DOLs and treatment leaders.
Track results of a real-life DOL analysis.